ABCB1 and cancer: The mechanism of MTD, which increases the efficacy of doxorubicine, a cytostatic used to treat other cancers, has been thought to be via blocking p-glycoprotein and thereby increasing drug concentration in the cells [10], but our current data suggest other mechanisms.